Related Experiment Video

Updated: May 25, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Bone mass loss in chronic heart failure is associated with secondary hyperparathyroidism and has prognostic

John Terrovitis1, Panagiotis Zotos, Elissavet Kaldara

  • 13rd Department of Cardiology, University of Athens, Greece.

European Journal of Heart Failure
|January 31, 2012
PubMed

Insights

Chronic heart failure patients experience bone loss and secondary hyperparathyroidism, linked to disease severity. Reduced bone density in heart failure predicts adverse outcomes, highlighting its prognostic significance.

Area of Science:

  • Cardiology
  • Endocrinology
  • Bone Metabolism

Background:

  • Chronic heart failure (CHF) is a condition associated with an increased risk of osteoporosis.
  • Understanding the relationship between CHF severity, bone loss, and underlying mechanisms is crucial for patient management.

Purpose of the Study:

  • To investigate the link between CHF severity and bone loss.
  • To explore the pathophysiological mechanisms driving bone density changes in heart failure.
  • To determine the prognostic significance of bone mass alterations in patients with CHF.

Main Methods:

  • Bone mineral density (BMD) and T-/Z-scores were measured in men with and without CHF.
  • Parathyroid hormone (PTH) and vitamin D levels were assessed.
  • A composite endpoint of death, left ventricular assist device (LVAD) implantation, or inotrope dependency was tracked over a 2-year follow-up.

Main Results:

  • Men with CHF exhibited significantly lower total body and femoral BMD, T-scores, and Z-scores compared to controls.
  • Elevated PTH levels were observed in CHF patients and correlated with reduced BMD and poorer cardiac function indicators (reduced cardiac index, VO2 peak; increased wedge pressure).
  • Disease severity (NYHA classes III-IV) was associated with lower BMD and higher PTH levels.
  • Low total body BMD and femur Z-score were significant predictors of adverse outcomes.

Conclusions:

  • Secondary hyperparathyroidism and reduced bone density are prevalent in CHF patients.
  • These bone changes are associated with the severity of chronic heart failure.
  • Increased bone loss in CHF carries significant prognostic implications for patient outcomes.
Abstract

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...